Skip to main content
Clinical Trials/NCT00569361
NCT00569361
Completed
Not Applicable

Nasal Epithelium Gene Expression Profiling in Child Respiratory Allergic

Centre Hospitalier Universitaire de Nice1 site in 1 country80 target enrollmentNovember 2004

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Allergic Rhinitis
Sponsor
Centre Hospitalier Universitaire de Nice
Enrollment
80
Locations
1
Primary Endpoint
Transcriptome analysis: genes statistically modulated between groups, predictive biomarkers allowing correct classification of groups
Status
Completed
Last Updated
16 years ago

Overview

Brief Summary

Using a human pangenomic microarray, the researchers established expression profiles of nasal epithelial cells, collected by brushing of patients belonging to one of four distinct groups:

  1. allergic rhinitis to dust mite (AR) isolated (n=12),
  2. AR associated with bronchial hyperreactivity (n=12),
  3. AR associated with asthma (n=14),
  4. control (n=14).

Detailed Description

Context: Asthma is the most frequent chronic disease in childhood. Allergic rhinitis has been described as a risk factor to develop asthma. The objective of the study was to evaluate the contribution of the respiratory epithelium to development of allergic rhinitis and asthma and to identify the molecular mechanisms driving rhinitis toward asthma. Methods: Using a human pangenomic microarray, we established expression profiles of nasal epithelial cells, collected by brushing of patients belonging to one of four distinct children 2 to 18 years of age groups: 1. allergic rhinitis to dust mite (AR) isolated (n=12), 2. AR associated with bronchial hyperreactivity (n=12), 3. AR associated with asthma (n=14), 4. control (n=14).

Registry
clinicaltrials.gov
Start Date
November 2004
End Date
October 2005
Last Updated
16 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients between 6 and 17 years old
  • Patients with allergic rhinitis
  • Patients between 6 and 17 years old
  • Patients without allergic rhinitis and asthma

Exclusion Criteria

  • Rhino-bronchitis infection dated from less than 15 days
  • Patients younger than 6 or older than 17 years

Outcomes

Primary Outcomes

Transcriptome analysis: genes statistically modulated between groups, predictive biomarkers allowing correct classification of groups

Time Frame: At the sample time

Secondary Outcomes

  • Validation with other techniques: Q-PCR(At the sample time)

Study Sites (1)

Loading locations...

Similar Trials